Skip to content

Long-term Adverse Effects After Bariatric Surgery on Oesophagus Epithelium

Long-term Adverse Effects After Laparoscopic Sleeve Gastrectomy and Roux en Y Gastric Bypass (Part B)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03410849
Acronym
FUB-B
Enrollment
170
Registered
2018-01-25
Start date
2018-02-01
Completion date
2020-09-01
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

The goal of this trial is to examine long-term effects of laparoscopic gastric bypass (LRYGB) and sleeve gastrectomy (LSG) on oesophageal symptoms and disease, including the presence of Barrett oesophagus ≥ 5 years post-surgery.

Detailed description

Bariatric surgery shows impressive results in terms of weight loss and resolution of comorbidities. Still, there are questions as to the frequency of long-term adverse effects: the prevalence and causes of post-operative swallowing disorders and reflux disease are uncertain. Recently, independent study groups described a high incidence of Barrett oesophagus post LSG. Additional research is urgently needed. The goal of this trial is to examine long-term effects of laparoscopic gastric bypass (LRYGB) and sleeve gastrectomy (LSG) on oesophageal symptoms and disease, including the presence of Barrett oesophagus ≥ 5 years post-surgery.

Interventions

DIAGNOSTIC_TESTGastroscopy

in both arms intervention 'gastroscopy' will be carried out

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who received laparoscopic gastric bypass or laparoscopic sleeve gastrectomy ≥ 5 years ago as a primary bariatric procedure will be eligible for this study.

Exclusion criteria

* Patients who received laparoscopic gastric bypass or laparoscopic sleeve gastrectomy as a secondary bariatric procedure (e.g. after gastric banding), * Patients who received a secondary bariatric operation after laparoscopic gastric bypass or laparoscopic sleeve gastrectomy( e.g. biliopancreatic diversion)

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Barrett oesophagus after bariatric surgery5-7 years after bariatric surgeryincidence of Barrett oesophagus will be compared to will be compared to reference for this age

Secondary

MeasureTime frameDescription
Prevalence of dysphagia after bariatric surgery5-7 years after bariatric surgeryPrevalence of dysphagia will be compared to will be compared to reference for this age
Prevalence of oesophageal motility disorders after bariatric surgery5-7 years after bariatric surgeryPrevalence of oesophageal motility will be compared to will be compared to reference for this age

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026